BioPharma Credit PLC (BPCR.L) stock: key figures, P/E, revenue and dividend

Financials · Asset Management & Custody Banks · United Kingdom · ISIN GB00BDGKMY29

Price
0.98 USD
Market cap
1.11 bn USD
P/E (2025)
8.56
P/S (2025)
7.93
Dividend yield
8.65 %
Net margin
92.62 %
Return on equity (ROE)
11.29 %
Return on assets (ROA)
11.12 %

BioPharma Credit PLC financials

Fiscal year20242025
Revenue124.46 m USD140.23 m USD
Gross profit124.46 m USD114.50 m USD
Operating income122.18 m USD129.85 m USD
EBIT244.36 m USD–
Net income122.18 m USD129.89 m USD
Diluted EPS – continuing operations0.10 USD0.11 USD

Full history since 2017, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About BioPharma Credit PLC

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.